About Ian Taylor
Form D filings for EvolveImmune Therapeutics Holding Company from 2023 to 2024 list Ian Taylor as director.
Ian Taylor first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Taylor in the role, so the role may have started earlier or lasted longer.
EvolveImmune Therapeutics Holding Company, LLC
Director
2023 – 2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.
Key Colleagues at Startups
The people Ian Taylor works with at each company, as listed on that company's latest Form D.
EvolveImmune Therapeutics Holding Company, LLC · Form D, Nov 1, 2024

Donmienne Leung
Director
DY
Derek Yoon
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director
JM
Jasmina Marjanovic
Director
DP
Denis Patrick
Director